Location: Home > Pharma China Web Edition
  • search
  • go
  • Product/R&D News
  • 10/24/2025Boehringer Ingelheim's Jascayd Wins NMPA Approval for IPF
  • 10/22/2025GenScript Wins NMPA IND Nod for Bispecific ADC GenSci139
  • 10/22/2025Zai Lab Launches First Phase 3 Trial of DLL3-Targeted ADC ZL-1310 in R...
  • 10/22/2025Multitude Reports Strong Efficacy for CD44v9-Targeted ADC AMT-116 at E...
  • 10/21/2025Henlius' PD-L1 ADC HLX43 Receives Orphan Drug Designation in the U.S.
  • 10/21/2025CSPC's JSKN003 Granted Breakthru Therapy Designation in China
  • 10/21/2025Kelun-Biotech's Sacituzumab Tirumotecan Shows Strong Phase 3 Results
  • 10/21/2025RemeGen's Disitamab Vedotin Plus Toripalimab Delivers Breakthru First-...
  • 10/21/2025Merck KGaA and Abbisko Report Strong Phase 3 Results for Pimicotinib a...
  • 10/20/2025Kelun Gains China Approval for First Homegrown HER2 Breast Cancer ADC
  • 10/20/2025Akeso Reports Strong China Data for Ivonescimab in Lung Cancer
  • 10/17/2025LEO Pharma's Anzupgo Cream NDA Accepted in China
  • 10/17/2025RemeGen's Telitacicept Demonstrates Strong Phase 3 Efficacy in Lupus, ...
  • 10/16/2025Belite Bio Secures Priority Review from China's NMPA for Tinlarebant
  • 10/16/2025Qilu Presents Promising Phase I Data for AR PROTAC Degrader QLH12016
  • 10/15/2025Sino Biopharma's TQB2102 Receives Breakthru Therapeutic Designation in...
  • 10/14/2025GSK's Shingrix Wins Chinese Approval for Expanded Use
  • 10/14/2025Biokin and SystImmune Present Promising Early Data for EGFR×HER3 Bisp...
  • 10/14/2025Multitude Reports Updated Safety and Dose Findings for AMT-116 at ESMO...
  • 10/14/2025AskBio Reports Promising Safety Results from First Cohort of AB-1003 G...
  • 10/13/2025Lepu Reports Early Clinical Data for ADC Programs in Various Cancers
  • 10/13/2025Hansoh Pharma Reports Phase II Data for Oral B7H3 ADC HS-20093
  • 10/13/2025Lundbeck's Epilepsy Drug Bexicaserin Granted Breakthrough Therapy Stat...
  • 10/13/2025Two Decades of Pediatric Drug Trials in China Reveal Progress and Pers...
  • 10/13/2025Kelun-Biotech Presents Promising Phase 1 Data for CLDN18.2 ADC SKB315
  • 10/13/20254B Technologies' Novel NGF Receptor Inhibitor 4B03-04 Receives FDA IND...
  • 10/13/2025Hope Medicine Reports Positive Global Phase 2 Results for HMI-115
  • 10/13/2025Kelun-Biotech Wins China Approval for TROP2 ADC in EGFR-Mutant NSCLC A...
  • 10/13/2025USB's Zilbrysq Wins Chinese Approval
  • 10/13/2025CSPC's Novel siRNA Therapy Gains U.S. Green Light for Clinical Trials
  • Page:9/22 Total number of articles:647: [First][<<] [7] [8] [9] [10] [11] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group